logo

For the Inventor, By the Inventor

Pearl River, NY, United States of America

Yansong Gu

This inventor holds 13 USPTO granted patents, plus 1 CIPO patent. Top assignees: Wyeth, American Cyanamid Company. Active years: 1999-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yansong Gu. Retrieved from https://idiyas.com/inventor/yansong-gu-29cua46b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 46.2

 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 98(Granted Patents)


Company Filing History:

goldMedal7 out of 1,309 
 
Wyeth
 patents
silverMedal6 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1999-2010

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 7691842 - Tricyclic 6-alkylidene-penems as β-lactamase inhibitors (2010-04-06),
2. 7332506 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2008-02-19),
3. 7235569 - Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use (2007-06-26),
4. 7148235 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2006-12-12),
5. 7018997 - Tricyclic 6-alkylidene-penems as β-lactamase inhibitors (2006-03-28),
6. 6939870 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2005-09-06),
7. 6667303 - Aryl substituted 1,4-diazepanes and method of use thereof (2003-12-23),
8. 6548524 - Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors (2003-04-15),
9. 6534491 - Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors (2003-03-18),
10. 6498167 - Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors (2002-12-24),
11. 6228869 - Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors (2001-05-08),
12. 5977408 - Preparation and use of .beta.-sulfonamido hydroxamic acids as matrix (1999-11-02),
13. 5929097 - Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix (1999-07-27),

Title: Yansong Gu: Innovator in Pharmaceutical Chemistry

Introduction

Yansong Gu is a prominent inventor based in Pearl River, NY (US), known for his significant contributions to pharmaceutical chemistry. With a total of 13 patents to his name, Gu has made remarkable strides in developing compounds that address critical health issues.

Latest Patents

Among his latest patents, Gu has developed "Tricyclic 6-alkylidene-penems as β-lactamase inhibitors." This invention provides a compound formula aimed at treating bacterial infections in patients. Another notable patent is for "Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression." This compound is designed to treat disorders of the serotonin-affected neurological systems, showcasing Gu's commitment to addressing mental health challenges.

Career Highlights

Throughout his career, Yansong Gu has worked with reputable companies such as Wyeth and American Cyanamid Company. His work in these organizations has allowed him to develop innovative solutions that have a lasting impact on the pharmaceutical industry.

Collaborations

Gu has collaborated with notable colleagues, including Aranapakam Mudumbai Venkatesan and Jeremy Ian Levin. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yansong Gu's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of bacterial infections and mental health disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…